Teeft.i
Exploration
Accueil
Racine
Exploration
Accueil
Racine

Serveur d'exploration H2N2 - Exploration (Accueil)

Index « Teeft.i » - entrée « Inhibitor »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Inhibition type < Inhibitor < Inhibitor acid group  Facettes :

List of bibliographic references indexed by Inhibitor

Number of relevant bibliographic references: 79.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000B09 (2012) Enguang Feng [République populaire de Chine] ; Deju Ye [République populaire de Chine] ; Jian Li [République populaire de Chine] ; Dengyou Zhang [République populaire de Chine] ; Jinfang Wang [République populaire de Chine] ; Fei Zhao [République populaire de Chine] ; Rolf Hilgenfeld [République populaire de Chine, Allemagne] ; Mingyue Zheng [République populaire de Chine] ; Hualiang Jiang [République populaire de Chine] ; Hong Liu [République populaire de Chine]Recent Advances in Neuraminidase Inhibitor Development as Anti‐influenza Drugs
000F39 (2010) Stephanie Bertram [Allemagne] ; Ilona Glowacka [Allemagne] ; Imke Steffen [Allemagne] ; Annika Kühl [Allemagne] ; Stefan Pöhlmann [Allemagne]Novel insights into proteolytic cleavage of influenza virus hemagglutinin
000F57 (2010) S. Yan [République populaire de Chine] ; G. Wu [République populaire de Chine]Evidence Obtained from anova to Reason Cross‐species Infection and Cross‐subtype Mutation in Neuraminidases of Influenza A Viruses
000F60 (2010) Guillermo Ruiz-Carrascoso [Espagne] ; Inmaculada Casas [Espagne] ; Francisco Pozo [Espagne] ; Carmen Pérez-González [Espagne] ; Jordi Reina [Espagne] ; Pilar Pérez-Bre A [Espagne]Development and implementation of influenza a virus subtyping and detection of genotypic resistance to neuraminidase inhibitors
001184 (2009) Mali Wirotesangthong [Thaïlande] ; Takayuki Nagai [Japon] ; Haruki Yamada [Japon] ; Surattana Amnuoypol [Thaïlande] ; Chutichot Mungmee [Thaïlande]Effects of Clinacanthus siamensis leaf extract on influenza virus infection
001322 (2008) Petr Niederhafner [République tchèque] ; Milan Reiniš [République tchèque] ; Jaroslav Šebestík [République tchèque] ; Jan Ježek [République tchèque]Glycopeptide dendrimers, Part III—a review: Use of glycopeptide dendrimers in immunotherapy and diagnosis of cancer and viral diseases
001340 (2008) Samson S. Y. Wong [Hong Kong] ; Kwok-Yung Yuen [Hong Kong]Antiviral therapy for respiratory tract infections
001425 (2007) W S Lim [Royaume-Uni]Pandemic flu: clinical management of patients with an influenza-like illness during an influenza pandemic
001612 (2005) Penelope Ward [Royaume-Uni] ; Ian Small [Royaume-Uni] ; James Smith [Suisse] ; Pia Suter [Suisse] ; Regina Dutkowski [États-Unis]Oseltamivir (Tamiflu®) and its potential for use in the event of an influenza pandemic
001676 (2004) Hiroshi Kido [Japon] ; Yuushi Okumura [Japon] ; Hiroshi Yamada [Japon] ; Dai Mizuno [Japon] ; Youichirou Higashi [Japon] ; Mihiro Yano [Japon]Secretory leukoprotease inhibitor and pulmonary surfactant serve as principal defenses against influenza A virus infection in the airway and chemical agents up-regulating their levels may have therapeutic potential
001721 (2003) Mikhail Matrosovich [Allemagne, Russie] ; Hans-Dieter Klenk [Allemagne]Natural and synthetic sialic acid‐containing inhibitors of influenza virus receptor binding
001775 (2002) Ralf Wagner [Allemagne] ; Mikhail Matrosovich [Allemagne, Russie] ; Hans-Dieter Klenk [Allemagne]Functional balance between haemagglutinin and neuraminidase in influenza virus infections
001786 (2002) Sebastian L. Johnston [Royaume-Uni]Anti-influenza therapies
001826 (2001) Robert A. Nathan ; Duncan Geddes ; Mark WoodheadManagement of influenza in patients with asthma or chronic obstructive pulmonary disease
001829 (2001) M. Louise Herlocher [États-Unis] ; Rob Fenton [Royaume-Uni] ; Andrew Merry [États-Unis] ; Stephanie Elias [États-Unis] ; Arnold S. Monto [États-Unis]Influenza resistance to zanamivir generated in ferrets
001834 (2001) Graphical Abstracts
001854 (2001) Michael G. Ison [États-Unis] ; Frederick G. Hayden [États-Unis]Therapeutic options for the management of influenza
001884 (2001) Alexander C. Schmidt [États-Unis] ; Robert B. Couch [États-Unis] ; George J. Galasso [États-Unis] ; Frederick G. Hayden [États-Unis] ; John Mills [Australie] ; Brian R. Murphy [États-Unis] ; Robert M. Chanock [États-Unis]Current research on respiratory viral infections: Third International Symposium
001909 (2000) V. Demicheli [Italie] ; T. Jefferson [Royaume-Uni] ; D. Rivetti [Italie] ; J. Deeks [Royaume-Uni]Prevention and early treatment of influenza in healthy adults
001916 (2000) Daniel Stamboulian ; Pablo E. Bonveh ; Francisco M. Nacinovich ; Nancy Cox [États-Unis]INFLUENZA
001927 (2000) Irina A. Leneva [États-Unis] ; Noel Roberts [Royaume-Uni] ; Elena A. Govorkova [États-Unis] ; Olga G. Goloubeva [États-Unis] ; Robert G. Webster [États-Unis]The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i -k "Inhibitor" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i  \
                -Sk "Inhibitor" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Teeft.i
   |clé=    Inhibitor
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021